Stock listing

Dusseldorf:BBZA BB Biotech AG Aktie

German listing (Dusseldorf) of BB Biotech AG · home listing SIX Swiss:BION

Follow BB Biotech AG into a list and get an email when it puts out news.

Home listing price · SIX:BION

52.60 CHF -0.20 (-0.4%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, SIX:BION

Past year +21.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
52.40 – 53.20 CHFNov 20, 2026
Volume
85,517 sharesNov 20, 2026
Market cap
2.90B CHFAt the close on Nov 20, 2026 · price × 55.15M shares outstanding
52-week range
41.05 – 57.00 CHFLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
4.10M CHFMedian day 73,928 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
BB Biotech AG logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
SIX Swiss:BION · Home52.60 CHF-0.20 (-0.4%)85,51752.5053.2052.4052.80Close on Nov 20, 2026
Xetra:BBZA€57.30 EUR+0.20 (+0.4%)5,508€56.80€57.50€56.70€57.10Close on Nov 20, 2026
Frankfurt:BBZA€55.60 EUR-1.30 (-2.3%)95€55.60€55.60€55.60€56.90Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · SIX:BION · CHF, adjusted for splits

DayCloseChange%OpenHighLowVolume
52.60-0.20-0.4%52.5053.2052.4085,517
52.800.000.0%52.7053.6052.7045,532
52.80-1.30-2.4%53.5053.6052.6050,853
54.10+0.10+0.2%54.1054.9053.8056,450
54.00-0.80-1.5%54.7055.0053.8058,030
54.80-0.10-0.2%55.2055.4054.2066,092
54.90+1.10+2.0%54.8055.2054.4090,736
53.80+0.30+0.6%53.7054.6053.7081,231
53.50+1.90+3.7%51.6053.7051.6070,512
51.60-0.30-0.6%51.0051.9050.3079,766
51.90+0.10+0.2%52.4053.3051.70112,262
51.80+0.20+0.4%51.3052.4051.0080,046
51.60+0.90+1.8%50.9051.8050.4041,937
50.70-0.60-1.2%51.2051.6050.7063,219
51.30+0.10+0.2%51.0052.1050.8070,194
51.20+1.00+2.0%50.2051.8050.2092,482
50.20-0.10-0.2%50.3050.6049.55246,871
50.30+0.90+1.8%49.1050.4049.1038,625
49.40+0.70+1.4%48.8550.0048.8563,914
48.70-1.30-2.6%49.9050.0048.7087,948
50.00-0.40-0.8%50.2050.6049.5069,402
50.40+0.20+0.4%50.3050.7050.0074,060
50.20+1.55+3.2%48.6550.5048.5579,341
48.65+0.50+1.0%48.0048.6547.8057,173
48.15-1.35-2.7%49.5049.5048.1063,070
49.50+0.75+1.5%48.3549.5048.3576,925
48.75-0.15-0.3%48.3049.3048.2090,673
48.90-0.60-1.2%49.4049.7048.8556,877
49.50+0.35+0.7%49.2049.9049.2068,495
49.15+1.35+2.8%48.2049.1548.2091,994
47.80-2.20-4.4%49.5049.5047.60148,695
50.00+0.35+0.7%49.0050.0049.0094,608
49.65+0.10+0.2%49.9550.4048.8077,709
49.55-0.75-1.5%50.0050.9049.2573,795
50.30-0.60-1.2%50.5050.6050.0089,976
50.90-1.00-1.9%51.5051.8050.7086,534
51.90+0.70+1.4%50.6051.9050.6057,889
51.20-0.20-0.4%51.4051.8050.9034,219
51.40+0.30+0.6%51.3051.4050.8052,385
51.10-0.10-0.2%51.3051.6050.9066,684
51.20-0.30-0.6%51.3051.5050.9049,332
51.50-0.70-1.3%52.3052.5051.2092,709
52.20+0.40+0.8%51.6052.3051.3061,806
51.80-0.50-1.0%52.1052.2051.5044,832
52.30+0.10+0.2%52.8052.8051.80216,260
52.20+0.50+1.0%52.2052.8052.00127,986
51.70-0.10-0.2%51.8052.0051.4053,631
51.80-0.60-1.1%52.2052.7051.3073,474
52.40-0.10-0.2%52.5053.0052.3046,645
52.50-0.30-0.6%52.6053.3052.2082,317
52.80-1.00-1.9%53.8053.9052.8056,652
53.80-0.10-0.2%53.7054.1053.5043,109
53.90-0.30-0.6%54.0054.7053.3081,033
54.20-0.90-1.6%54.8055.0054.2049,739
55.10-0.60-1.1%55.4055.9055.1068,313
55.70-0.20-0.4%56.0056.0055.2061,704
55.90+0.40+0.7%55.8056.9055.6087,209
55.50-0.40-0.7%56.0056.0054.50135,101
55.90-0.10-0.2%55.8056.2055.6089,543
56.00-0.80-1.4%56.6056.9055.9079,319
56.80+0.60+1.1%56.5056.9056.0076,530
56.20-0.50-0.9%56.6056.8055.9095,369
56.70+1.20+2.2%55.7057.0055.7094,315
55.50-0.40-0.7%55.2055.5054.9084,643
55.90+0.80+1.5%54.9055.9054.6054,740
55.10-0.40-0.7%55.9055.9054.5091,592

Splits

2 splits since 2001 · SIX:BION · every price before a split is adjusted for it

DayRatioWhat
5-for-1Split
10-for-1Split
Ticker
Dusseldorf:BBZA
Asset type
Stock
Sector
Financials
Industry
Investment companies & funds
Exchange
Dusseldorf
Currency
EUR

What changed lately

Latest news

All BB Biotech AG news

BB Biotech AG on 6ix

Sector
Financials
Industry
Investment companies & funds
News releases
8 in the last 12 months · 11 in all · newest Jul 24, 2026 · oldest 2025
Calls
1 call with a replay · 1 with a transcript · latest Feb 20, 2026

Where BB Biotech AG is listed

ListingExchangeCountryCurrency
SIX Swiss:BION · Home listingSIX SwissSwitzerlandCHF
Xetra:BBZAXetraGermanyEUR
gettex:BBZAgettexGermanyEUR
Tradegate:BBZATradegateGermanyEUR
Lang & Schwarz:A0NFN3Lang & SchwarzGermanyEUR
Frankfurt:BBZAFrankfurtGermanyEUR
Aquis:BIONZAquisUnited KingdomCHF
LSIN:0JYOLSINUnited KingdomCHF
LS Exchange:A0NFN3LS ExchangeGermanyEUR
BX Swiss:BBZABX SwissSwitzerlandCHF
Dusseldorf:BBZA · This pageDusseldorfGermanyEUR
VIE:BIONViennaAustriaEUR
Stuttgart:BBZAStuttgartGermanyEUR
Turquoise:BIONZTurquoiseUnited KingdomCHF
Hamburg:BBZAHamburgGermanyEUR
Hanover:BBZAHanoverGermanyEUR
Munich:BBZAMunichGermanyEUR
OTC:BBAGFOTCUnited StatesUSD
Aquis:BBZADAquisUnited KingdomEUR
Aquis:BBZADAquisUnited KingdomEUR
Turquoise:BBZADTurquoiseUnited KingdomEUR

Valuation

P/E 2.7× against a median of 13.2×: the lowest of 7 Investment companies & funds companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−394.8M CHF
P/E
2.7×
EV/sales
−1.8×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
0.9×
Gross margin
100.0%
Operating margin
490.7%
Net margin
490.6%
Debt to equity
0.0×
Beta
No index for this market yet

Investment companies & funds: the 10 companies nearest in size, of 321 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
BB Biotech AG · SIX:BIONUS$3.45B−US$470.2M2.7×−1.8×n/a0.9×490.6%0.0×n/a
Main Street Capital Corporation · NYSE:MAINUS$5.17BUS$7.65B11.6×10.9×15.6×1.6×63.6%0.8×0.58
E-L Financial Corporation Limited · TSX:ELFUS$4.53BUS$4.70B3.6×1.7×n/a0.7×46.7%0.1×0.63
Blue Owl Technology Finance Corp. · NYSE:OTFUS$4.07BUS$11.05B11.3×7.9×17.9×0.5×25.6%0.9×0.64
Wendel SE · EURONEXT:MFUS$3.48BUS$8.06Bn/a0.9×5.2×1.0×−1.9%1.8×n/a
Pershing Square USA, Ltd. · NYSE:PSUSUS$3.38BUS$3.38Bn/an/an/a3,437×n/a0.0×0.99
Tata Investment Corporation Limited · NSE:TATAINVESTUS$3.18BUS$3.18B74.0×70.2×77.1×0.9×95.0%0.0×n/a
Golub Capital BDC, Inc. · NASDAQ:GBDCUS$3.18BUS$7.32B33.3×n/an/a0.9×n/a1.2×0.38
FS KKR Capital Corp. · NYSE:FSKUS$2.96BUS$9.02Bn/a10.0×11.5×0.6×−57.5%1.3×0.67
Caledonia Investments PLC · LSE:CLDNUS$2.60BUS$2.49B14.7×11.4×14.0×0.7×81.5%0.0×n/a
Investco Holding A.S. · BIST:INVESUS$2.58BUS$2.49Bn/a169×524×4.3×−54.5%0.0×n/a
Median of the othersUS$3.28BUS$6.01B13.2×10.5×15.6×0.9×36.1%0.5×0.64

Forecasts

Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
73.00 CHF · Analysts' mean
EPS, year to Dec 2026
-0.61 · 1 analyst
Revenue, year to Dec 2026
1.28B · 1 analyst

Team and board

Officers

OfficerRole
Rachael BurriHead Investor Relations
Christian KochHead BB Biotech Team
Kyle RasbachHead Research

Board

DirectorRole
Thomas von PlantaChairman
Mads Krogsgaard ThomsenVice-Chairman

Events

Next results
Feb 19, 2027 (expected)

Calls

CallWhenStatus
BB Biotech (SIX Swiss: BION) Q4 2025 Earnings CallFri, Feb 20, 2026 · 4:00 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Oct 23, 2026 · After close+1.4%
Q2 2026Jul 24, 2026 · After close+2.6%
Q1 2026Apr 24, 2026 · After close+1.0%
Q4 2025Feb 20, 2026 · After close+1.2%
Q3 2025Oct 24, 2025 · After close+3.1%
Q2 2025Jul 25, 2025 · After close+1.8%
Q1 2025Apr 25, 2025 · Before open+1.8%
Q4 2024Feb 21, 2025 · Before open+1.7%
Q3 2024Oct 25, 2024 · Before open−3.9%
Q2 2024Jul 26, 2024 · Before open+1.0%
All 20 quarters
QuarterResultsShare move
Q1 2024Apr 26, 2024 · Before open−0.3%
Q4 2023Jan 19, 2024 · Before open−0.8%
Q3 2023Oct 20, 2023 · Before open−2.4%
Q2 2023Jul 21, 2023 · Before open−2.5%
Q1 2023Apr 21, 2023 · Before open−2.8%
Q4 2022Feb 20, 2023 · Before open+0.2%
Q3 2022Oct 21, 2022 · Before open+0.4%
Q2 2022Jul 22, 2022 · Before open+0.5%
Q1 2022Apr 22, 2022 · Before open−3.0%
Q4 2021Feb 18, 2022 · Before open−1.4%

Open Events

Financials

Annual, in CHF

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue76.8M111.6M35.0K-351.2M-396.2M699.2M685.2M-465.8M693.1M-796.4M
Cost of revenue55.0K4.98M5.80M1.73M986.0K883.0K1.24M1.09M542.0K1.08M
Gross profit76.8M111.6M35.0K-351.2M-396.2M699.2M685.2M-465.8M693.1M-796.4M
Selling, general and administrative7.60M27.2M4.23M4.26M6.06M5.23M4.66M2.73M3.14M3.39M
Operating income586.8M84.4M-29.9M-356.0M-404.7M691.2M677.5M-470.2M688.1M-800.9M
Depreciation and amortization90.0K166.7M314.3M343.6M206.3K171.9K40.6M688.1M27.8M
EBITDA84.5M136.7M-41.8M-61.1M691.5M677.7M-429.6M1.38B-773.1M
Interest expense443.0K4.98M5.80M1.73M986.0K883.0K1.24M1.09M542.0K1.08M
Income before tax578.2M76.0M-206.5M-357.8M-404.7M691.2M677.5M-471.3M687.6M-802.0M
Income tax66.0K54.0K79.0K61.0K67.0K75.0K68.0K71.0K77.0K71.0K
Net income578.1M75.9M-206.6M-357.8M-404.8M691.2M677.4M-471.3M687.5M-802.1M
Earnings per share, basic10.541.38-3.77-6.46-7.3112.4812.23-8.5112.42-14.51

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents98.2M458.0K501.0K1.95M2.83M6.82M30.7M22.1M10.7M10.2M
Short-term investments1.20M2.41B2.63B3.04B3.64B3.95B3.52B3.06B3.62B3.20B
Receivables5.51M01.83M1.52M334.0K010.2M
Inventory-2.64B-3.96B-3.06B-3.22B
Current assets104.9M2.41B2.64B1.95M2.83M3.96B30.7M22.4M10.7M20.4M
Total assets2.79B2.41B2.64B3.05B3.64B3.96B3.55B3.09B3.64B3.23B
Accounts payable3.54M3.22M3.49M2.88M
Current liabilities121.1M16.7M367.3M360.6M75.6M3.54M3.22M3.49M2.88M
Total debt117.5M304.9M363.0M355.0M63.0M150.0M185.0M95.0M205.0M
Total liabilities6.97M121.1M313.9M367.3M355.0M63.0M161.6M202.3M99.1M223.2M
Shareholders' equity2.78B2.29B2.32B2.69B3.28B3.89B3.39B2.88B3.54B3.00B
Shares outstanding54.8M54.8M54.8M55.4M55.4M55.4M55.4M55.4M55.4M55.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations309.1M304.6M218.3M-357.8M-404.8M262.4M215.0M-471.3M687.5M-802.1M
Capital spending0000000000
Free cash flow309.1M304.6M218.3M-357.8M-404.8M262.4M215.0M-471.3M687.5M-802.1M
Cash from investing588.9M579.1M-424.0M917.5M
Cash from financing-203.2M-305.2M-220.2M-233.3M91.8M-284.5M-205.2M-93.9M-263.0M-126.8M
Dividends paid-98.5M-109.7M-156.3M-212.2M-199.4M-188.4M-169.0M-182.8M-152.1M-160.5M
Share buybacks-5.04M-3.13M0-27.3M-9.46M-8.26M0-19.1M-54.2M
Change in cash97.8M-43.0K-1.45M-887.0K-3.98M-23.9M8.63M11.3M501.0K-10.8M

Open Financials

Cap table

Built by 6ix from BB Biotech AG’s releases

Common shares
55,149,250
Fully diluted
55,149,250

Fully diluted

LineShares
Common shares55,149,250

Share count over time

CountShares
Nov 22, 202655,149,250

Open Cap table

Shareholders

Register

HolderSharesOf the companyAs of
UBS Fund Management (Switzerland) AG2.79M5.0%Mar 30, 2026
Saba Capital Management, L.P.1.72M3.1%Aug 10, 2026
Swisscanto Fondsleitung AGOct 28, 2026

Big stakes

StakeStakeSharesDateFiling
UBS Fund Management (Switzerland) AG5.03%2.79MMar 30, 2026SIX significant shareholder notification
Saba Capital Management, L.P.5.01%1.72MAug 10, 2026SIX significant shareholder notification

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Christian KochHead BB Biotech Team · Since at least Jul 24, 2026
Kyle RasbachHead Research · Since at least Apr 24, 2026
Mads Krogsgaard ThomsenVice-Chairman · Since at least Apr 24, 2026
Rachael BurriHead Investor Relations · Since at least Apr 24, 2026
Thomas von PlantaChairman · Since at least Apr 24, 2026

Open People

Log in to ask 6ix AI your own questions about BB Biotech AG.